Suppression of mitochondrial respiration through recruitment of p160 myb binding protein to PGC-1α: modulation by p38 MAPK
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The transcriptional coactivator PPAR gamma coactivator 1 alpha (PGC-1alpha) is a key regulator of metabolic processes such as mitochondrial biogenesis and respiration in muscle and gluconeogenesis in liver. Reduced levels of PGC-1alpha in humans have been associated with type II diabetes. PGC-1alpha contains a negative regulatory domain that attenuates its transcriptional activity. This negative regulation is removed by phosphorylation of PGC-1alpha by p38 MAPK, an important kinase downstream of cytokine signaling in muscle and beta-adrenergic signaling in brown fat. We describe here the identification of p160 myb binding protein (p160MBP) as a repressor of PGC-1alpha. The binding and repression of PGC-1alpha by p160MBP is disrupted by p38 MAPK phosphorylation of PGC-1alpha. Adenoviral expression of p160MBP in myoblasts strongly reduces PGC-1alpha's ability to stimulate mitochondrial respiration and the expression of the genes of the electron transport system. This repression does not require removal of PGC-1alpha from chromatin, suggesting that p160MBP is or recruits a direct transcriptional suppressor. Overall, these data indicate that p160MBP is a powerful negative regulator of PGC-1alpha function and provide a molecular mechanism for the activation of PGC-1alpha by p38 MAPK. The discovery of p160MBP as a PGC-1alpha regulator has important implications for the understanding of energy balance and diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Phosphorylation of PGC-1α by p38 prevents interaction with p160 repressor [77, 78] and increases protein stability [34].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [77]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,260 · cited 2×
“Nuclear extracts were prepared from C2C12 myoblasts using the Dignam protocol (Dignam et al. 1983).”
MethodMootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Self-citationWu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139 · cited 3×
“PGC-1 activates mitochondrial biogenesis and respiration in both brown fat and skeletal muscle, and is induced in the cold in both tissues (Puigserver et al. 1998; Wu et al. 1999).”
BackgroundMethodSelf-citationA Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864 · cited 12×
“To study the effects of p160MBP and p67MBP on PGC-1 in a more native context, we cotransfected vectors expressing these proteins with PGC-1 and one of its transcription factor targets, PPAR .”
BackgroundInfluentialSelf-citationTranscriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres
Lin, J., Wu, H., Tarr, P. T., Zhang, C.-Y., Wu, Z., Boss, O., Michael, L. F., Puigserver, P., Isotani, E., Olson, E. N., et al. (2002) · Nature · doi:10.1038/nature00904 · Cited by 2,546 · cited 4×
“Importantly, expression of PGC-1 in skeletal muscle in vivo via a transgene triggers the conversion of type IIb muscle fibers to type IIa and type I fibers, as evidenced by mitochondrial biogenesis and expression of myofibrillar proteins characteristic of slow-twitch muscle (Lin et al. 2002; Handschin et al. 2003).”
BackgroundInfluentialSelf-citationAnti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., & Cerami, A. (1987) · Nature · doi:10.1038/330662a0 · Cited by 2,448 · cited 1×
“The p38 MAPK sites are highly conserved across species and are downstream of both cytokine and -adrenergic signaling cascades (Tracey et al. 1987; Cao et al. 2001).”
BackgroundPuigserver, P., & Spiegelman, B. M. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0012 · Cited by 2,076 · cited 1×
“…partner for PPAR (Puigserver et al. 1998), but interacts with and coactivates many transcription factors, such as nuclear respiratory factor 1 (NRF-1), myocyte-enhancing factor2C (MEF2C), and most members of the nuclear hormone receptor family (for review, see Puigserver and Spiegelman 2003).”
BackgroundSelf-citationPatti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952 · cited 2×
“Most recently, decreases in skeletal muscle PGC-1 have been associated with human type 2 diabetes and those at risk for the development of diabetes (Mootha et al. 2003; Patti et al. 2003).”
BackgroundControl of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821 · cited 2×
“PGC-1 is induced in liver in response to fasting, and activates key genes of the fasting response, including the genes of the gluconeogenic pathway and -oxidation of fatty acids (Herzig et al. 2001; Yoon et al. 2001; Puigserver et al. 2003; Rhee et al. 2003).”
BackgroundSelf-citationInsulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487 · cited 1×
“PGC-1 is induced in liver in response to fasting, and activates key genes of the fasting response, including the genes of the gluconeogenic pathway and -oxidation of fatty acids (Herzig et al. 2001; Yoon et al. 2001; Puigserver et al. 2003; Rhee et al. 2003).”
BackgroundSelf-citation
Cited by
Butyrate improves insulin sensitivity and increases energy expenditure in mice
Gao, Z., Yin, J., Zhang, J., Ward, R. E., Martin, R. J., Lefevre, M., Cefalu, W. T., & Ye, J. (2009) · Diabetes · doi:10.2337/db08-1637 · Cited by 2,204
“associated with PGC-1α in the basal condition (35).”
BackgroundMetabolic control through the PGC-1 family of transcription coactivators
Lin, J., Handschin, C., & Spiegelman, B. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.004 · Cited by 2,130
“These modifications also enhance the transcriptional activity of PGC-1α by displacing p160 myb binding protein (p160MBP), a strong transcriptional suppressor (Fan et al., 2004).”
BackgroundPGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure
Cantó, C., & Auwerx, J. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328328d0a4 · Cited by 1,624
PGC-1 coactivators: inducible regulators of energy metabolism in health and disease
Finck, B. N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27794 · Cited by 1,432
Regulation of pgc-1α, a nodal regulator of mitochondrial biogenesis
Fernandez-Marcos, P. J., & Auwerx, J. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.001917 · Cited by 1,237
Defects in Adaptive Energy Metabolism with CNS-Linked Hyperactivity in PGC-1α Null Mice
Lin, J., Wu, P.-H., Tarr, P. T., Lindenberg, K. S., St-Pierre, J., Zhang, C.-Y., Mootha, V. K., Jäger, S., Vianna, C. R., Reznick, R. M., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.013 · Cited by 1,162
Self-citationHandschin, C., & Spiegelman, B. M. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0037 · Cited by 1,090
Self-citationTranscriptional integration of mitochondrial biogenesis
Scarpulla, R. C., Vega, R. B., & Kelly, D. P. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.06.006 · Cited by 798
Akimoto, T., Pohnert, S. C., Li, P., Zhang, M., Gumbs, C., Rosenberg, P. B., Williams, R. S., & Yan, Z. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408862200 · Cited by 714
Gibala, M. J., & McGee, S. L. (2008) · Exercise and Sport Sciences Reviews · doi:10.1097/jes.0b013e318168ec1f · Cited by 682
“8 PGC-1> activity is acutely regulated by p160myb, a powerful repressor of PGC-1> function (10).”
BackgroundPGC-1 α, Inflammation, and Oxidative Stress: An Integrative View in Metabolism
Rius-Pérez, S., Torres-Cuevas, I., Millán, I., Ortega, Á. L., & Pérez, S. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1452696 · Cited by 642
Transcriptional Control of Mitochondrial Biogenesis and Function
Hock, M. B., & Kralli, A. (2009) · Annual Review of Physiology · doi:10.1146/annurev.physiol.010908.163119 · Cited by 614
“At the posttranslational level, PGC-1α activity is regulated via phosphorylation by mitogenactivated protein kinase (MAPK) p38, AKT, AMPK, and glycogen synthase kinase-3 (GSK3) (93, 95, 99, 114, 115), (de)acetylation by GCN5 and Sirtuin 1 (SIRT1) (92, 116), arginine methylation by PRMT1 (117), ubiquitination by SCFcdc…”
BackgroundInfluentialMitochondrial-nuclear communications
Ryan, M. T., & Hoogenraad, N. J. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.052305.091720 · Cited by 575
Metabolic adaptations through the PGC‐1α and SIRT1 pathways
Rodgers, J. T., Lerin, C., Gerhart-Hines, Z., & Puigserver, P. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.034 · Cited by 561
“In addition to enhanced stability, the activity is further increased due to the inability of the phospho-PGC-1a to bind the p160 corepressor [9].”
BackgroundMitochondrial energy metabolism in heart failure: a question of balance
Huss, J. M., & Kelly, D. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524405 · Cited by 533
Exercise-induced mitochondrial biogenesis begins before the increase in muscle PGC-1α expression.
Wright, D. C., Han, D.-H., Garcia-Roves, P. M., Geiger, P. C., Jones, T. E., & Holloszy, J. O. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606116200 · Cited by 488
Nuclear Receptor Signaling and Cardiac Energetics
Huss, J. M., & Kelly, D. P. (2004) · Circulation Research · doi:10.1161/01.res.0000141774.29937.e3 · Cited by 473
AMP-activated protein kinase and its downstream transcriptional pathways
Cantó, C., & Auwerx, J. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0454-z · Cited by 421
“PGC-1a phosphorylation might not directly affect its intrinsic coactivation activity, but, rather, release it from its repressor protein p160myb [79] and/or allow deacetylation”
BackgroundVillena, J. A. (2015) · The FEBS Journal · doi:10.1111/febs.13175 · Cited by 405
Scarpulla, R. C. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.006 · Cited by 391
The transcriptional coactivator PGC-1α mediates exercise-induced angiogenesis in skeletal muscle
Chinsomboon, J., Ruas, J., Gupta, R. K., Thom, R., Shoag, J., Rowe, G. C., Sawada, N., Raghuram, S., & Arany, Z. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909131106 · Cited by 379
Biological control through regulated transcriptional coactivators
Spiegelman, B. M., & Heinrich, R. (2004) · Cell · doi:10.1016/j.cell.2004.09.037 · Cited by 377
Self-citationCoordination of metabolic plasticity in skeletal muscle
Hood, D. A., Irrcher, I., Ljubicic, V., & Joseph, A.-M. (2006) · Journal of Experimental Biology · doi:10.1242/jeb.02182 · Cited by 370
“Upon phosphorylation by p38 MAPK, the inhibitory effect of the repressor protein was relieved, permitting PGC-1 to recruit, interact with and co-activate proteins to induce target gene expression (Fan et al., 2004; Knutti et al., 2001).”
BackgroundMitochondrial biogenesis and healthy aging
López-Lluch, G., Irusta, P. M., Navas, P., & de Cabo, R. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.06.014 · Cited by 364
PGC-1 Coactivators in Cardiac Development and Disease
Rowe, G. C., Jiang, A., & Arany, Z. (2010) · Circulation Research · doi:10.1161/circresaha.110.223818 · Cited by 355
Little, J. P., Safdar, A., Bishop, D., Tarnopolsky, M. A., & Gibala, M. J. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00538.2010 · Cited by 342
Diverse physiological functions for dual-specificity MAP kinase phosphatases
Dickinson, R. J., & Keyse, S. M. (2006) · Journal of Cell Science · doi:10.1242/jcs.03266 · Cited by 329
“p38 MAPK can regulate energy expenditure via activation of peroxisome proliferator-activated receptor gamma (PPARg) coactivator 1a (PGC-1a) (Fan et al., 2004) and mice lacking ERK1 display resistance to diet-induced obesity coupled with protection from the development of insulin resistance (Bost et al.”
BackgroundPGC-1α and PGC-1Β Regulate Mitochondrial Density in Neurons
Wareski, P., Vaarmann, A., Choubey, V., Safiulina, D., Liiv, J., Kuum, M., & Kaasik, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.018911 · Cited by 294
After the banquet: Mitochondrial biogenesis, mitophagy, and cell survival
Zhu, J., Wang, K. Z., & Chu, C. T. (2013) · Autophagy · doi:10.4161/auto.24135 · Cited by 293
Mitochondrial dysfunction and lipotoxicity
Schrauwen, P., Schrauwen-Hinderling, V., Hoeks, J., & Hesselink, M. K. C. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.011 · Cited by 268
Tumors and Mitochondrial Respiration: A Neglected Connection
Viale, A., Corti, D., & Draetta, G. F. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0491 · Cited by 266
“Moreover PGC1a is directly phosphorylated by p38 at different residues (37), and these modifications modulate its stability, increasing PGC1a half-life and activity (38, 39).”
Pathania, D., Millard, M., & Neamati, N. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.010 · Cited by 263
Activation of nuclear receptor coactivator PGC-1α by arginine methylation
Teyssier, C., Ma, H., Emter, R., Kralli, A., & Stallcup, M. R. (2005) · Genes & Development · doi:10.1101/gad.1295005 · Cited by 260
“HA-CARM1, encoding HA-CARM1; pGEX4T1.CARM1, encoding GSTCARM1 (Chen et al. 1999); pHE0, encoding human estrogen receptor (Green et al. 1988); and the luciferase reporter plasmid for ER, MMTV(ERE)-LUC (Umesono and Evans 1989).”
BackgroundRegulation of mitochondrial biogenesis and PGC-1α under cellular stress
Wenz, T. (2013) · Mitochondrion · doi:10.1016/j.mito.2013.01.006 · Cited by 256
“Both RIP140 and 160MYP suppress mitochondrial biogenesis (Fan et al., 2004; Powelka et al., 2006).”
BackgroundHuman Multipotent Adipose-Derived Stem Cells Differentiate into Functional Brown Adipocytes
Elabd, C., Chiellini, C., Carmona, M., Galitzky, J., Cochet, O., Petersen, R., Pénicaud, L., Kristiansen, K., Bouloumié, A., Casteilla, L., et al. (2009) · Stem Cells · doi:10.1002/stem.200 · Cited by 252
PPARγ signaling and emerging opportunities for improved therapeutics
Wang, S., Dougherty, E. J., & Danner, R. L. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.02.028 · Cited by 248
PGC-1 coactivators and skeletal muscle adaptations in health and disease
Arany, Z. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.07.018 · Cited by 246
Peroxisome Proliferator Activator Receptor γ Coactivator-1 Expression Is Reduced in Obesity
Crunkhorn, S., Dearie, F., Mantzoros, C., Gami, H., da Silva, W. S., Espinoza, D., Faucette, R., Barry, K., Bianco, A. C., & Patti, M. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611214200 · Cited by 236
Dannenberg, J.-H., David, G., Zhong, S., van der Torre, J., Wong, W. H., & DePinho, R. A. (2005) · Genes & Development · doi:10.1101/gad.1286905 · Cited by 221
“Furthermore, regulation of gene expression through the PPAR pathway appears subject to regulation by histone deacetylation (Fan et al. 2004).”
BackgroundTwist-1 Is a PPARδ-Inducible, Negative-Feedback Regulator of PGC-1α in Brown Fat Metabolism
Pan, D., Fujimoto, M., Lopes, A., & Wang, Y.-X. (2009) · Cell · doi:10.1016/j.cell.2009.01.051 · Cited by 218
Housley, M. P., Udeshi, N. D., Rodgers, J. T., Shabanowitz, J., Puigserver, P., Hunt, D. F., & Hart, G. W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808890200 · Cited by 216
A new activating role for CO in cardiac mitochondrial biogenesis
Suliman, H. B., Carraway, M. S., Tatro, L. G., & Piantadosi, C. A. (2007) · Journal of Cell Science · doi:10.1242/jcs.03318 · Cited by 214
“We did not explore the disruption of PGC-1 binding to p160 myb – a negative regulator of its transcriptional activity and of respiration (Fan et al., 2004) – by p38 or the cross-talk postulated between p38 and PI3-K/Akt (Iwasa et al., 2003), because p38 signaling in the heart is complex.”
BackgroundRetractedPGC-1α and ERRα target gene downregulation is a signature of the failing human heart
Sihag, S., Cresci, S., Li, A. Y., Sucharov, C. C., & Lehman, J. J. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.10.025 · Cited by 214
“Alterations in p38 MAPK with associated post-translational modification of PGC-1α have been demonstrated to impact the transcriptional capacity of PGC-1α by increasing PGC-1α protein stability [74], promoting dissociation of a repressor [75,76], and enhancing selective activation of PPARα [77].”
BackgroundIsoflavones Promote Mitochondrial Biogenesis
Rasbach, K. A., & Schnellmann, R. G. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.134882 · Cited by 206
“The regulation of PGC-1 expression is under the control of several signaling pathways involving nitric oxide, calcium/ calmodulin-dependent protein kinases, calcineurin A, AMPactivated protein kinase, and p38 MAPK (Barger et al., 2001; Zong et al., 2002; Handschin et al., 2003; Suwa et al., 2003, 2006; Yu et al., 2003…”
BackgroundInfluentialThe hitchhiker’s guide to PGC-1α isoform structure and biological functions
Martínez-Redondo, V., Pettersson, A. T., & Ruas, J. L. (2015) · Diabetologia · doi:10.1007/s00125-015-3671-z · Cited by 202
“Kinases that target PGC-1α1 include p38 mitogen-activated protein kinase [20], protein kinase B [21], S6 kinase [22], AMPK [23] and glycogen synthase kinase 3β (GSK3β) [24].”
BackgroundMiller, V. J., Villamena, F. A., & Volek, J. S. (2018) · Journal of Nutrition and Metabolism · doi:10.1155/2018/5157645 · Cited by 199
“PGC-1α is activated by p38 MAPK [283, 303] through phosphorylation [304], which prevents repression [303] by blocking interaction with the p160 myb binding protein [304].”
BackgroundRegulation of neuron mitochondrial biogenesis and relevance to brain health
Onyango, I. G., Lu, J., Rodova, M., Lezi, E., Crafter, A. B., & Swerdlow, R. H. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.07.014 · Cited by 188
“11 arginine methylation [89, 97-100].”
Álvarez-Guardia, D., Palomer, X., Coll, T., Davidson, M. M., Chan, T. O., Feldman, A. M., Laguna, J. C., & Vázquez-Carrera, M. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq080 · Cited by 187
Olson, B. L., Hock, M. B., Ekholm-Reed, S., Wohlschlegel, J. A., Dev, K. K., Kralli, A., & Reed, S. I. (2008) · Genes & Development · doi:10.1101/gad.1624208 · Cited by 185
“Phosphorylation at these sites increases the transcriptional activity of PGC-1 , at least partly via the release of inhibitory factors such as p160 myb-binding protein (Knutti et al. 2001; Puigserver et al. 2001; Fan et al. 2004).”
BackgroundMetabolic and genetic regulation of cardiac energy substrate preference
Kodde, I. F., van der Stok, J., Smolenski, R. T., & de Jong, J. W. (2007) · Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2006.09.014 · Cited by 179
“Stimuli that are associated with increased PGC-1α activity and expression include: p38 MAP kinase, βadrenergic action/cAMP, NO, AMPK and Ca-calmodulin kinase (Boss et al., 1999; Fan et al., 2004; Nisoli et al., 2004).”
BackgroundRegulatory circuits controlling white versus brown adipocyte differentiation
Hansen, J. B., & Kristiansen, K. (2006) · Biochemical Journal · doi:10.1042/bj20060402 · Cited by 178
Signaling of Mitochondrial Biogenesis following Oxidant Injury
Rasbach, K. A., & Schnellmann, R. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608009200 · Cited by 168
Hallberg, M., Morganstein, D. L., Kiskinis, E., Shah, K., Kralli, A., Dilworth, S. M., White, R., Parker, M. G., & Christian, M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00504-08 · Cited by 164
“Interestingly, the region of amino acids 186 to 408 is known to inhibit transcriptional activation (41), and so it is conceivable that, in addition to the p160 myb binding protein ( 13 ), the recruitment of RIP140 may contribute to repression.”
BackgroundAcute endurance exercise increases the nuclear abundance of PGC-1α in trained human skeletal muscle
Little, J. P., Safdar, A., Cermak, N., Tarnopolsky, M. A., & Gibala, M. J. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00409.2009 · Cited by 162
PGC-1α in aging and anti-aging interventions
Anderson, R., & Prolla, T. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.04.005 · Cited by 162
“Phosphorylation of PGC-1α by p38 prevents interaction with p160 repressor [77,78] and increases protein stability [34].”
Unravelling the mechanisms regulating muscle mitochondrial biogenesis
Hood, D. A., Tryon, L. D., Carter, H. N., Kim, Y., & Chen, C. C. W. (2016) · Biochemical Journal · doi:10.1042/bcj20160009 · Cited by 159
Biochemistry of the tale transcription factors PREP, MEIS, and PBX in vertebrates
Longobardi, E., Penkov, D., Mateos, D., De Florian, G., Torres, M., & Blasi, F. (2014) · Developmental Dynamics · doi:10.1002/dvdy.24016 · Cited by 162
“Hence, in the absence of PREP1, MYBBP1A fails to inhibit the transcriptional activity of PGC1A in muscle cells, increasing insulin sensitivity (Oriente et al., 2008).”
BackgroundPGC-1β Deficiency Accelerates the Transition to Heart Failure in Pressure Overload Hypertrophy
Riehle, C., Wende, A. R., Zaha, V. G., Pires, K. M., Wayment, B., Olsen, C., Bugger, H., Buchanan, J., Wang, X., Moreira, A. B., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.243964 · Cited by 156
PGC-1α, glucose metabolism and type 2 diabetes mellitus
Wu, H., Deng, X., Shi, Y., Su, Y., Wei, J., & Duan, H. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0021 · Cited by 167
The WSTF-SNF2h Chromatin Remodeling Complex Interacts with Several Nuclear Proteins in Transcription
Cavellán, E., Asp, P., Percipalle, P., & Farrants, A. Ö. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600233200 · Cited by 170
Mitochondria and PGC-1α in Aging and Age-Associated Diseases
Wenz, T. (2011) · Journal of Aging Research · doi:10.4061/2011/810619 · Cited by 148
“Both molecules suppress mitochondrial biogenesis [49, 50].”
Backgroundp38 Mitogen-activated Protein Kinase Plays a Stimulatory Role in Hepatic Gluconeogenesis
Cao, W., Collins, Q. F., Becker, T. C., Robidoux, J., Lupo, E. G., Xiong, Y., Daniel, K. W., Floering, L., & Collins, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506223200 · Cited by 145
Watt, M. J., Southgate, R. J., Holmes, A. G., & Febbraio, M. A. (2004) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01499 · Cited by 144
“This finding is consistent with previous work in C2C12 myotubes which demonstrated no increase in PGC1 mRNA despite p38 MAPK activation (Fan et al. 2003).”
BackgroundResultMitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets
Izzo, A., Mollo, N., Nitti, M., Paladino, S., Calì, G., Genesio, R., Bonfiglio, F., Cicatiello, R., Barbato, M., Sarnataro, V., et al. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0004-y · Cited by 141
“Indirectly PREP1 controls the stability of p160 MybBinding Protein, a powerful negative regulator of PGC1α activity (Fan et al. 2004).”
PGC-1α: a potent transcriptional cofactor involved in the pathogenesis of type 2 diabetes
Soyal, S. M., Krempler, F., Oberkofler, H., & Patsch, W. (2006) · Diabetologia · doi:10.1007/s00125-006-0268-6 · Cited by 162
“... 1α[40].Suchamechanismalso controlsthecoactivation of PPARα at a multipartite response element within the promoter region of the gene encoding uncoupling protein (UCP)1[11].Conversely,thismechanismdoesnotregulate coactivation ofPPARγ,RARorLXRbyPGC-1α[10].The MYBbindingprotein(P160)1awasidentifiedasaPGC-1α repressor…”
BackgroundRegulation of skeletal muscle mitochondrial fatty acid metabolism in lean and obese individuals
Holloway, G. P., Bonen, A., & Spriet, L. L. (2008) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26717b · Cited by 175
“These observations underscore the complexity of mechanisms that regulate protein expression, including the influence of phosphorylation on increasing PGC1a mRNA stability (50) or activation (51), the ability of other proteins to suppress PGC1a activity (52), and the importance of nuclear import (53).”
BackgroundEffects of Wnt Signaling on Brown Adipocyte Differentiation and Metabolism Mediated by PGC-1α
Kang, S., Bajnok, L., Longo, K. A., Petersen, R. K., Hansen, J. B., Kristiansen, K., & MacDougald, O. A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.4.1272-1282.2005 · Cited by 137
“PGC-1 is itself regulated by transcriptional coactivators, including SRC-1, TIF2, and p160 myb ( 15 , 40).”
BackgroundPGC-1α negatively regulates hepatic FGF21 expression by modulating the heme/Rev-Erbα axis
Estall, J. L., Ruas, J. L., Choi, C. S., Laznik, D., Badman, M., Maratos-Flier, E., Shulman, G. I., & Spiegelman, B. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912533106 · Cited by 134
“PGC-1 (cid:1) can associate with proteins that negatively affect its coactivator function (e.g., p160/Mib) (14, 15), but there is no evidence that PGC-1s can directly mediate transcriptional repression.”
BackgroundVan Laar, V. S., & Berman, S. B. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.05.015 · Cited by 131
Perry, C. G. R., & Hawley, J. A. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029686 · Cited by 130
“The p38 MAPK phosphorylates and activates PGC-1 a (Knutti et al. 2001; Puigserver et al. 2001; Fan et al. 2004) and translocates PGC-1 a from the cytoplasm to the nucleus before increases in gene transcripts for mitochondrial proteins (Wright 2007).”
Cochran, A. J. R., Percival, M. E., Tricarico, S., Little, J. P., Cermak, N., Gillen, J. B., Tarnopolsky, M. A., & Gibala, M. J. (2014) · Experimental Physiology · doi:10.1113/expphysiol.2013.077453 · Cited by 123
“The results of our acute investigation (study 1) showed that both INT and CONT protocols elicited similar increases in signalling cascades linked to mitochondrial biogenesis, including the protein phosphorylation of ACC and p38 MAPK and the mRNA expression of PGC-1α.”
BackgroundInfluentialp38 Mitogen-activated Protein Kinase Mediates Free Fatty Acid-induced Gluconeogenesis in Hepatocytes
Collins, Q. F., Xiong, Y., Lupo, E. G., Liu, H.-Y., & Cao, W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602177200 · Cited by 122
Yeo, W. K., McGee, S. L., Carey, A. L., Paton, C. D., Garnham, A. P., Hargreaves, M., & Hawley, J. A. (2010) · Experimental Physiology · doi:10.1113/expphysiol.2009.049353 · Cited by 117
“The MAPK pathways include the stress-activated protein kinase, p38 MAPK, which has been reported to be involved in mediating skeletal muscle adaptive responses to endurance training (Fan et al. 2004; Akimoto et al. 2005).”
BackgroundPGC-1α controls mitochondrial biogenesis and dynamics in lead-induced neurotoxicity
Dabrowska, A., Venero, J. L., Iwasawa, R., Hankir, M.-K., Rahman, S., Boobis, A., & Hajji, N. (2015) · Aging · doi:10.18632/aging.100790 · Cited by 121
The metabolic modulator PGC-1α in cancer.
Bost, F., & Kaminski, L. (2019) · Europe PMC (PubMed Central) · Cited by 169
Disruption of TBP-2 ameliorates insulin sensitivity and secretion without affecting obesity
Yoshihara, E., Fujimoto, S., Inagaki, N., Okawa, K., Masaki, S., Yodoi, J., & Masutani, H. (2010) · Nature Communications · doi:10.1038/ncomms1127 · Cited by 118
“Intriguingly, Mybbp1a is reported to inhibit PGC-1α function and transcription of PGC-1α target gene”
BackgroundSeparation of the gluconeogenic and mitochondrial functions of PGC-1α through S6 kinase
Lustig, Y., Ruas, J. L., Estall, J. L., Lo, J. C., Devarakonda, S., Laznik, D., Choi, J. H., Ono, H., Olsen, J. V., & Spiegelman, B. M. (2011) · Genes & Development · doi:10.1101/gad.2054711 · Cited by 116
“Direct binding of the corepressor p160MBP also represses PGC-1a activity (Fan et al. 2004).”
BackgroundSano, M., Tokudome, S., Shimizu, N., Yoshikawa, N., Ogawa, C., Shirakawa, K., Endo, J., Katayama, T., Yuasa, S., Ieda, M., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703634200 · Cited by 114
Role of metabolic stress for enhancing muscle adaptations: Practical applications
de Freitas, M. C., Gerosa-Neto, J., Zanchi, N. E., Lira, F. S., & Rossi, F. E. (2017) · World Journal of Methodology · doi:10.5662/wjm.v7.i2.46 · Cited by 146
The biology of PGC-1α and its therapeutic potential
Handschin, C. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.03.006 · Cited by 108
Self-citationSUMOylation Attenuates the Function of PGC-1α
Rytinki, M. M., & Palvimo, J. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.038943 · Cited by 108
Corton, J. C., & Brown-Borg, H. M. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.12.1494 · Cited by 106
Mitochondrial Metabolic Reprogramming Induced by Calorie Restriction
Martin-Montalvo, A., & de Cabo, R. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4866 · Cited by 104
“This interaction is further regulated by p38 mitogen-activated protein kinase (MAPK), which phosphorylates the inhibitory domain of PGC-1 a , thereby disrupting p160MBP-binding and inducing mitochondrial biogenesis (26).”
Carson, J. A., Hardee, J. P., & VanderVeen, B. N. (2016) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.11.005 · Cited by 103
Prmt7 Deficiency Causes Reduced Skeletal Muscle Oxidative Metabolism and Age-Related Obesity
Jeong, H.-J., Lee, H.-J., Vuong, T. A., Choi, K.-S., Choi, D., Koo, S.-H., Cho, S. C., Cho, H., & Kang, J.-S. (2016) · Diabetes · doi:10.2337/db15-1500 · Cited by 101
“We showed that MEF2c and MyoD were reduced in Prmt72/2 mice.”
BackgroundInfluentialThe complex crosstalk between mitochondria and the nucleus: What goes in between?
Cagin, U., & Enríquez, J. A. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.01.026 · Cited by 123
p38 MAPK in Glucose Metabolism of Skeletal Muscle: Beneficial or Harmful?
Bengal, E., Aviram, S., & Hayek, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186480 · Cited by 114
“At another level, p38 MAPK directly phosphorylates the PGC-1α protein to promote its stability and activity [8].”
BackgroundInfluentialRegulation of Hypoxia-Inducible Genes by PGC-1α
Shoag, J., & Arany, Z. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.181636 · Cited by 96
Herzog, B., Hallberg, M., Seth, A., Woods, A., White, R., & Parker, M. G. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0213 · Cited by 95
p38 Mitogen-activated Protein Kinase Plays an Inhibitory Role in Hepatic Lipogenesis
Xiong, Y., Collins, Q. F., An, J., Lupo, E., Liu, H.-Y., Liu, D., Robidoux, J., Liu, Z., & Cao, W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606742200 · Cited by 93
Clark, J., & Simon, D. K. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2241 · Cited by 93
Benton, C. R., Wright, D. C., & Bonen, A. (2008) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h08-074 · Cited by 91
PGC‐1α activation as a therapeutic approach in mitochondrial disease
Wenz, T. (2009) · IUBMB Life · doi:10.1002/iub.261 · Cited by 91
“main that attenuates its transcriptional activity and the p160 myb binding protein (p160MYB) acts as a repressor of PGC-a by binding to this regulatory domain (85).”
BackgroundMitochondrial dynamics in cancer-induced cachexia
van der Ende, M., Grefte, S., Plas, R., Meijerink, J., Witkamp, R. F., Keijer, J., & van Norren, K. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.07.008 · Cited by 87
Regulation of Mitochondrial Biogenesis and GLUT4 Expression by Exercise
Holloszy, J. O. (2011) · Comprehensive Physiology · doi:10.1002/cphy.c100052 · Cited by 85
The Emerging Role of p53 in Exercise Metabolism
Bartlett, J. D., Close, G. L., Drust, B., & Morton, J. P. (2013) · Sports Medicine · doi:10.1007/s40279-013-0127-9 · Cited by 104
“Both p38MAPK [31] and AMPK [32] can directly phosphorylate PGC-1a on different sites, thereby resulting in increased activity and subsequent translocation to both the nucleus [33] and mitochondria [34] during acute exercise.”
BackgroundChang, J. S., Huypens, P., Zhang, Y., Black, C., Kralli, A., & Gettys, T. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.083121 · Cited by 84
Intercellular: local and systemic actions of skeletal muscle PGC-1s
Correia, J. C., Ferreira, D. M. S., & Ruas, J. L. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.03.010 · Cited by 95
Timmons, J. A., Norrbom, J., Schéele, C., Thonberg, H., Wahlestedt, C., & Tesch, P. (2006) · Genomics · doi:10.1016/j.ygeno.2005.09.007 · Cited by 79
“This substantial volume of evidence has positioned PGC-1a as playing a central role in the development of Type 2 diabetes [14] and led to the premature conclusion that PGC-1a activation is a logical objective for a diabetes drug development program [4,13,19].”
BackgroundMetabolic roles of PGC-1α and its implications for type 2 diabetes
Besseiche, A., Riveline, J., Gautier, J., Bréant, B., & Blondeau, B. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.02.002 · Cited by 97
“This omain comprises the L3 pattern, allowing binding to one or ore repressor proteins [6,10], such as p160/MBP protein, in ultured myoblasts.”
Background
Metadata
- Authors
- Fan, M., Rhee, J., St-Pierre, J., Handschin, C., Puigserver, P., Lin, J., Jäeger, S., Erdjument-Bromage, H., Tempst, P., & Spiegelman, B. M.
- Affiliations
- Harvard University (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2004-01-26
- Volume
- 18
- Issue
- 3
- Pages
- 278-289
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC338281
- OpenAlex
- W6931824552
- Cited by
- 309
- References
- 30
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 9 · 2023: 5 · 2022: 8 · 2021: 5 · 2020: 12 · 2019: 9 · 2018: 13 · 2017: 10 · 2016: 8 · 2015: 13 · 2014: 10 · 2013: 19 · 2012: 18
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- edoc (University of Basel) (submittedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- edoc (University of Basel)
- Funders
- National Institutes of Health (DK54477, CA08748)
- National Eye Institute (5T32EY07110, T32EY007110)
- National Cancer Institute (P30-CA-08748, CA08748, P30CA008748)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK54477, R56DK054477, R01DK054477)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- mitochondrial respiration, PGC-1α, p38 MAPK, transcriptional coactivator, mitochondrial biogenesis, oxidative phosphorylation
- MeSH terms
- Animals, Carrier Proteins, Cells, Cultured, DNA-Binding Proteins, Energy Metabolism, Gene Expression Regulation, Mitochondria, Muscle, Nuclear Proteins, Repressor Proteins, Transcription Factors, Transcription, Genetic, Transfection, RNA-Binding Proteins, Receptors, Cytoplasmic and Nuclear, Muscle, Skeletal, Cell Respiration, Mitogen-Activated Protein Kinases, MAP Kinase Signaling System, Nucleocytoplasmic Transport Proteins, p38 Mitogen-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.